☒ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Georgia
|
58-1027114
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
4370 Peachtree Road, N.E.,
Atlanta, Georgia
|
30319
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $1.00 per share
|
AAME
|
NASDAQ Global Market
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
Emerging growth company ☐
|
Page
|
||
1
|
||
PART I
|
||
Item 1.
|
1
|
|
1
|
||
3
|
||
3
|
||
4
|
||
4
|
||
6
|
||
6
|
||
7
|
||
7
|
||
8
|
||
8
|
||
8
|
||
9
|
||
10 | ||
10
|
||
10
|
||
10
|
||
Item 1A.
|
11
|
|
Item 1B.
|
11
|
|
Item 2.
|
11
|
|
Item 3.
|
11
|
|
Item 4.
|
11
|
|
PART II
|
||
Item 5.
|
12
|
|
Item 6.
|
12
|
|
Item 7.
|
13
|
|
Item 7A.
|
20
|
|
Item 8.
|
21
|
|
Item 9.
|
51
|
|
Item 9A.
|
51
|
|
Item 9B.
|
51
|
|
Item 9C.
|
51
|
|
PART III
|
||
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
52
|
Item 11.
|
Executive Compensation
|
52
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
|
52
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
52
|
Item 14.
|
Principal Accountant Fees and Services
|
52
|
PART IV
|
||
Item 15.
|
53
|
|
Item 16.
|
54
|
55
|
|
56
|
|
59
|
|
61
|
|
62
|
Item 1. |
Business
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Automobile liability
|
$
|
30,453
|
$
|
30,312
|
||||
Automobile physical damage
|
22,917
|
18,730
|
||||||
General liability
|
5,637
|
3,891
|
||||||
Surety
|
5,620
|
5,857
|
||||||
Other lines
|
3,355
|
3,582
|
||||||
Total
|
$
|
67,982
|
$
|
62,372
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Life insurance
|
$
|
10,557
|
$
|
9,270
|
||||
Medicare supplement
|
95,314
|
102,680
|
||||||
Other accident and health
|
10,363
|
9,217
|
||||||
Total health insurance
|
105,677
|
111,897
|
||||||
Total
|
$
|
116,234
|
$
|
121,167
|
December 31,
|
||||||||||||||||
2021
|
2020
|
|||||||||||||||
Amount
|
Percent
|
Amount
|
Percent
|
|||||||||||||
(Dollars in thousands)
|
||||||||||||||||
Fixed maturities:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
50,298
|
17.7
|
%
|
$
|
30,762
|
11.0
|
%
|
||||||||
States, municipalities and political subdivisions
|
11,644
|
4.2
|
11,802
|
4.2
|
||||||||||||
Public utilities
|
13,952
|
4.9
|
13,651
|
4.9
|
||||||||||||
All other corporate bonds
|
184,842
|
65.2
|
197,641
|
70.8
|
||||||||||||
Redeemable preferred stock
|
250
|
0.1
|
250
|
0.1
|
||||||||||||
Total fixed maturities(1)
|
260,986
|
92.1
|
254,106
|
91.0
|
||||||||||||
Equity securities(2)
|
19,124
|
6.7
|
18,716
|
6.7
|
||||||||||||
Other invested assets(3)
|
198
|
0.1
|
3,238
|
1.2
|
||||||||||||
Policy loans(4)
|
1,858
|
0.7
|
1,975
|
0.7
|
||||||||||||
Real estate
|
38
|
0.0
|
38
|
0.0
|
||||||||||||
Investments in unconsolidated trusts
|
1,238
|
0.4
|
1,238
|
0.4
|
||||||||||||
Total investments
|
$
|
283,442
|
100.0
|
%
|
$
|
279,311
|
100.0
|
%
|
(1) |
Fixed maturities are carried on the balance sheet at estimated fair value. Certain fixed maturities do not have publicly quoted prices, and are carried at estimated fair value as determined by management. Total amortized cost of fixed
maturities was $238.6 million as of December 31, 2021 and $222.5 million as of December 31, 2020.
|
(2) |
Equity securities are carried on the balance sheet at estimated fair value. Total cost of equity securities was $4.9 million as of December 31, 2021 and $6.4 million as of December 31, 2020.
|
(3) |
Other invested assets are accounted for using the equity method. Total cost of other invested assets was $0.7 million as of December 31, 2021 and $3.8 million as of December 31, 2020.
|
(4) |
Policy loans are valued at unpaid principal balances.
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(Dollars in thousands)
|
||||||||
Average investments(1)
|
$
|
260,240
|
$
|
252,141
|
||||
Net investment income
|
8,528
|
7,744
|
||||||
Average yield on investments
|
3.3
|
%
|
3.1
|
%
|
||||
Realized investment gains, net
|
4,903
|
7,420
|
(1) |
Calculated as the average of cash and investment balances (at amortized cost) at the beginning of the year and at the end of each of the succeeding four quarters.
|
Name
|
Age
|
Positions with the Company
|
Director or Officer Since
|
|||
Hilton H. Howell, Jr.
|
59
|
Chairman of the Board, President & CEO
|
1992
|
|||
J. Ross Franklin
|
44
|
Vice President, CFO and Corporate Secretary
|
2017
|
Item 1A. |
Risk Factors
|
Item 1B. |
Unresolved Staff Comments
|
Item 2. |
Properties
|
Item 3. |
Legal Proceedings
|
Item 4. |
Mine Safety Disclosures
|
Item 5. |
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
|
Period
|
Total
Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total
Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
|
Maximum
Number of Shares
that May Yet be
Purchased Under the
Plans or Programs
|
||||||||||||
October 1 – October 31, 2021
|
—
|
$
|
—
|
—
|
325,129
|
|||||||||||
November 1 – November 30, 2021
|
—
|
—
|
—
|
325,129
|
||||||||||||
December 1 – December 31, 2021
|
—
|
—
|
—
|
325,129
|
||||||||||||
Total
|
—
|
$
|
—
|
—
|
Item 6. |
Reserved
|
Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Revenue
|
||||||||
Property and Casualty:
|
||||||||
American Southern
|
$
|
73,868
|
$
|
69,179
|
||||
Life and Health:
|
||||||||
Bankers Fidelity
|
125,702
|
127,144
|
||||||
Corporate and Other
|
(16
|
)
|
(975
|
)
|
||||
Total revenue
|
$
|
199,554
|
$
|
195,348
|
||||
Income before income taxes
|
||||||||
Property and Casualty:
|
||||||||
American Southern
|
$
|
9,292
|
$
|
10,436
|
||||
Life and Health:
|
||||||||
Bankers Fidelity
|
3,726
|
12,430
|
||||||
Corporate and Other
|
(7,716
|
)
|
(7,363
|
)
|
||||
Income before income taxes
|
$
|
5,302
|
$
|
15,503
|
||||
Net income
|
$
|
4,281
|
$
|
12,169
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Reconciliation of Non-GAAP Financial Measure
|
||||||||
Net income
|
$
|
4,281
|
$
|
12,169
|
||||
Income tax expense
|
1,021
|
3,334
|
||||||
Realized investment gains, net
|
(4,903
|
)
|
(7,420
|
)
|
||||
Unrealized (gains) losses on equity securities, net
|
(1,894
|
)
|
3,431
|
|||||
Non-GAAP operating income (loss)
|
$
|
(1,495
|
)
|
$
|
11,514
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(Dollars in thousands)
|
||||||||
Gross written premiums
|
$
|
75,914
|
$
|
70,256
|
||||
Ceded premiums
|
(6,511
|
)
|
(5,890
|
)
|
||||
Net written premiums
|
$
|
69,403
|
$
|
64,366
|
||||
Net earned premiums
|
$
|
67,982
|
$
|
62,372
|
||||
Insurance benefits and losses incurred
|
44,433
|
39,339
|
||||||
Commissions and underwriting expenses
|
20,143
|
19,404
|
||||||
Underwriting income
|
$
|
3,406
|
$
|
3,629
|
||||
Loss ratio
|
65.4
|
%
|
63.1
|
%
|
||||
Expense ratio
|
29.6
|
31.1
|
||||||
Combined ratio
|
95.0
|
%
|
94.2
|
%
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Automobile liability
|
$
|
30,453
|
$
|
30,312
|
||||
Automobile physical damage
|
22,917
|
18,730
|
||||||
General liability
|
5,637
|
3,891
|
||||||
Surety
|
5,620
|
5,857
|
||||||
Other lines
|
3,355
|
3,582
|
||||||
Total
|
$
|
67,982
|
$
|
62,372
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(Dollars in thousands)
|
||||||||
Medicare supplement
|
$
|
162,400
|
$
|
174,525
|
||||
Other health products
|
10,364
|
9,218
|
||||||
Life insurance
|
10,624
|
9,348
|
||||||
Gross earned premiums
|
183,388
|
193,091
|
||||||
Ceded premiums
|
(67,154
|
)
|
(71,924
|
)
|
||||
Net earned premiums
|
116,234
|
121,167
|
||||||
Insurance benefits and losses incurred
|
87,261
|
80,537
|
||||||
Commissions and underwriting expenses
|
34,715
|
34,177
|
||||||
Total expenses
|
121,976
|
114,714
|
||||||
Underwriting income (loss)
|
$
|
(5,742
|
)
|
$
|
6,453
|
|||
Loss ratio
|
75.1
|
%
|
66.5
|
%
|
||||
Expense ratio
|
29.9
|
28.2
|
||||||
Combined ratio
|
105.0
|
%
|
94.7
|
%
|
Item 7A. |
Quantitative and Qualitative Disclosures About Market Risk
|
Item 8. |
Financial Statements and Supplementary Data
|
Page
|
|
ATLANTIC AMERICAN CORPORATION
|
|
Report of Independent Registered Public Accounting Firm (Dixon Hughes Goodman, LLP, Atlanta, GA PCAOB Firm ID No. 57)
|
22
|
24
|
|
25
|
|
26
|
|
27
|
|
28
|
|
29
|
|
•
|
Involving our actuarial specialists to assist in our procedures in:
|
|
o
|
Evaluating the appropriateness of management’s actuarial reserving methodologies and assumptions;
|
|
o
|
Evaluating management’s hindsight analyses;
|
|
o
|
Comparing management’s carried reserve to the range calculated by management’s specialist for property casualty claim reserves;
|
|
•
|
Testing the completeness and accuracy of data provided by management that served as the basis for the actuarial analyses on a sample basis; and
|
|
•
|
Evaluating movement of the Company’s recorded property casualty claim reserves within the Company’s estimated reserve range year over year.
|
|
•
|
Involving our actuarial specialists to assist in our procedures in:
|
|
o
|
Evaluating whether the methodology applied by management is consistent in the aggregate with the methodology compliant with GAAP;
|
|
o
|
Assessing the significant assumptions used by management for new insurance contracts issued during the current year by comparing the significant assumptions
noted above to historical experience, observable market data or management’s estimates of prospective changes to these assumptions;
|
|
o
|
Performing an independent recalculation of policy reserves for a sample of contracts for comparison to management’s estimate; and
|
|
o
|
Evaluating management’s loss recognition testing of aggregate reserve sufficiency.
|
|
•
|
Testing the completeness and accuracy of data used by management in developing assumptions on a sample basis.
|
December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands,
except share and per share data)
|
||||||||
ASSETS
|
||||||||
Cash and cash equivalents
|
$
|
24,753
|
$
|
19,319
|
||||
Investments:
|
||||||||
Fixed maturities, available-for-sale, at fair value (amortized cost: $238,597
and $222,461)
|
260,986
|
254,106
|
||||||
Equity securities, at fair value (cost: $4,907 and $6,393)
|
19,124
|
18,716
|
||||||
Other invested assets (cost: $698 and $3,765)
|
198
|
3,238
|
||||||
Policy loans
|
1,858
|
1,975
|
||||||
Real estate
|
38
|
38
|
||||||
Investment in unconsolidated trusts
|
1,238
|
1,238
|
||||||
Total investments
|
283,442
|
279,311
|
||||||
Receivables:
|
||||||||
Reinsurance
|
27,416
|
29,086
|
||||||
Insurance premiums and other, net of allowance for doubtful accounts of $188 and
$198 as of 2021
and 2020, respectively
|
14,959
|
27,512
|
||||||
Deferred income taxes, net
|
1,755
|
—
|
||||||
Deferred acquisition costs
|
38,698
|
39,611
|
||||||
Other assets
|
8,719
|
7,804
|
||||||
Intangibles
|
2,544
|
2,544
|
||||||
Total assets
|
$
|
402,286
|
$
|
405,187
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
Insurance reserves and policyholder funds
|
||||||||
Future policy benefits
|
$
|
87,348
|
$
|
90,872
|
||||
Unearned premiums
|
27,469
|
27,131
|
||||||
Losses and claims
|
85,620
|
79,147
|
||||||
Other policy liabilities
|
1,360
|
1,526
|
||||||
Total insurance reserves and policyholder funds
|
201,797
|
198,676
|
||||||
Accounts payable and accrued expenses
|
25,465
|
26,412
|
||||||
Deferred income taxes, net
|
—
|
1,301
|
||||||
Junior subordinated debenture obligations, net
|
33,738
|
33,738
|
||||||
Total liabilities
|
261,000
|
260,127
|
||||||
Commitments and contingencies (Note 16)
|
||||||||
Shareholders’ equity:
|
||||||||
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000
shares issued and outstanding; $5,500 redemption value
|
55
|
55
|
||||||
Common stock, $1 par, 50,000,000 shares authorized; 22,400,894 shares
issued; 20,378,576 and 20,415,243
shares outstanding as of 2021 and 2020, respectively
|
22,401
|
22,401
|
||||||
Additional paid-in capital
|
57,441
|
57,437
|
||||||
Retained earnings
|
51,264
|
47,790
|
||||||
Accumulated other comprehensive income
|
17,688
|
25,000
|
||||||
Unearned stock grant compensation
|
(73
|
)
|
(284
|
)
|
||||
Treasury stock, at cost, 2,022,318 and 1,985,651 shares as of 2021 and 2020, respectively
|
(7,490
|
)
|
(7,339
|
)
|
||||
Total shareholders’ equity
|
141,286
|
145,060
|
||||||
Total liabilities and shareholders’ equity
|
$
|
402,286
|
$
|
405,187
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands,
except per share data)
|
||||||||
Revenue:
|
||||||||
Insurance premiums, net
|
$
|
184,216
|
$
|
183,539
|
||||
Net investment income
|
8,528
|
7,744
|
||||||
Realized investment gains, net
|
4,903
|
7,420
|
||||||
Unrealized gains (losses) on equity securities, net
|
1,894
|
(3,431
|
)
|
|||||
Other income
|
13
|
76
|
||||||
Total revenue
|
199,554
|
195,348
|
||||||
Benefits and expenses:
|
||||||||
Insurance benefits and losses incurred
|
131,694
|
119,876
|
||||||
Commissions and underwriting expenses
|
47,496
|
46,811
|
||||||
Interest expense
|
1,387
|
1,610
|
||||||
Other expense
|
13,675
|
11,548
|
||||||
Total benefits and expenses
|
194,252
|
179,845
|
||||||
Income before income taxes
|
5,302
|
15,503
|
||||||
Income tax expense
|
1,021
|
3,334
|
||||||
Net Income
|
4,281
|
12,169
|
||||||
Preferred stock dividends
|
(399
|
)
|
(399
|
)
|
||||
Net Income applicable to common shareholders
|
$
|
3,882
|
$
|
11,770
|
||||
Earnings per common share (basic)
|
0.19
|
0.58
|
||||||
Earnings per common share (diluted)
|
$
|
0.19
|
$
|
0.56
|
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Net income
|
$
|
4,281
|
$
|
12,169
|
||||
Other comprehensive income:
|
||||||||
Available-for-sale fixed maturity securities:
|
||||||||
Gross unrealized holding gain (loss) arising in the period
|
(8,686
|
)
|
18,791
|
|||||
Related income tax effect
|
1,824
|
(3,946
|
)
|
|||||
Subtotal
|
(6,862
|
)
|
14,845
|
|||||
Less: reclassification adjustment for net realized gains included in net income
|
(570
|
)
|
(385
|
)
|
||||
Related income tax effect
|
120
|
81
|
||||||
Subtotal
|
(450
|
)
|
(304
|
)
|
||||
Total other comprehensive income (loss), net of tax
|
(7,312
|
)
|
14,541
|
|||||
Total comprehensive income (loss)
|
$
|
(3,031
|
)
|
$
|
26,710
|
Year Ended December 31,
|
||||||||
(In thousands, except share and per share data)
|
2021
|
2020
|
||||||
Preferred stock:
|
||||||||
Balance, beginning of year
|
$
|
55
|
$
|
55
|
||||
Balance, end of year
|
55
|
55
|
||||||
Common stock:
|
||||||||
Balance, beginning of year
|
22,401
|
22,401
|
||||||
Balance, end of year
|
22,401
|
22,401
|
||||||
Additional paid-in capital:
|
||||||||
Balance, beginning of year
|
57,437
|
57,820
|
||||||
Restricted stock grants, net of forfeitures
|
—
|
(376
|
)
|
|||||
Issuance of shares under stock plans
|
4
|
(7
|
)
|
|||||
Balance, end of year
|
57,441
|
57,437
|
||||||
Retained earnings:
|
||||||||
Balance, beginning of year
|
47,790
|
36,020
|
||||||
Net income
|
4,281
|
12,169
|
||||||
Dividends on common stock
|
(408
|
)
|
—
|
|||||
Dividends accrued on preferred stock
|
(399
|
)
|
(399
|
)
|
||||
Balance, end of year
|
51,264
|
47,790
|
||||||
Accumulated other comprehensive income:
|
||||||||
Balance, beginning of year
|
25,000
|
10,459
|
||||||
Other comprehensive income (loss), net of tax
|
(7,312
|
)
|
14,541
|
|||||
Balance, end of year
|
17,688
|
25,000
|
||||||
Unearned stock grant compensation:
|
||||||||
Balance, beginning of year
|
(284
|
)
|
(781
|
)
|
||||
Restricted stock grants, net of forfeitures
|
—
|
60
|
||||||
Amortization of unearned compensation
|
211
|
437
|
||||||
Balance, end of year
|
(73
|
)
|
(284
|
)
|
||||
Treasury stock:
|
||||||||
Balance, beginning of year
|
(7,339
|
)
|
(7,580
|
)
|
||||
Restricted stock grants, net of forfeitures
|
—
|
316
|
||||||
Net shares acquired related to employee share-based compensation plans
|
(153
|
)
|
(91
|
)
|
||||
Issuance of shares under stock plans
|
2
|
16
|
||||||
Balance, end of year
|
(7,490
|
)
|
(7,339
|
)
|
||||
Total shareholders’ equity
|
$
|
141,286
|
$
|
145,060
|
||||
Dividends declared on common stock per share
|
$
|
0.02
|
$
|
—
|
||||
Common shares outstanding:
|
||||||||
Balance, beginning of year
|
20,415,243 | 20,472,162 | ||||||
Net shares acquired under employee share-based compensation plans
|
(38,147 | ) | (46,620 | ) | ||||
Issuance of shares under stock plans
|
1,480 | 4,701 | ||||||
Restricted stock grants, net of forfeitures
|
— | (15,000 | ) | |||||
Balance, end of year
|
20,378,576 | 20,415,243 |
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
(In thousands)
|
||||||||
Cash flows from operating activities:
|
||||||||
Net Income
|
$
|
4,281
|
$
|
12,169
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Amortization of deferred acquisition costs
|
24,064
|
19,393
|
||||||
Acquisition costs deferred
|
(23,151
|
)
|
(20,143
|
)
|
||||
Realized investment gains, net
|
(4,903
|
)
|
(7,420
|
)
|
||||
Unrealized (gains) losses on equity securities, net
|
(1,894
|
)
|
3,431
|
|||||
Distributions received from equity method investees
|
290
|
—
|
||||||
Compensation expense related to share awards
|
211
|
437
|
||||||
Depreciation and amortization
|
1,003
|
980
|
||||||
Deferred income tax benefit
|
(1,112
|
)
|
(2,250
|
)
|
||||
Decrease in receivables, net
|
1,545
|
1,349
|
||||||
Increase (decrease) in insurance reserves and policyholder funds
|
3,121
|
(3,230
|
)
|
|||||
(Decrease) increase in accounts payable and accrued expenses
|
(947
|
)
|
2,324
|
|||||
Other, net
|
(1,420
|
)
|
1,931
|
|||||
Net cash provided by operating activities
|
1,088
|
8,971
|
||||||
Cash flows from investing activities:
|
||||||||
Proceeds from investments sold
|
29,184
|
18,541
|
||||||
Proceeds from investments matured, called or redeemed
|
11,515
|
7,117
|
||||||
Investments purchased
|
(35,292
|
)
|
(27,489
|
)
|
||||
Additions to property and equipment
|
(107
|
)
|
(233
|
)
|
||||
Net cash provided by (used in) investing activities
|
5,300
|
(2,064
|
)
|
|||||
Cash flows from financing activities:
|
||||||||
Payment of dividends on Series D preferred stock
|
(399
|
)
|
(399
|
)
|
||||
Payment of dividends on common stock
|
(408
|
)
|
—
|
|||||
Proceeds from shares issued under stock plans
|
6
|
9
|
||||||
Treasury stock acquired — net employee share-based compensation
|
(153
|
)
|
(91
|
)
|
||||
Net cash used in financing activities
|
(954
|
)
|
(481
|
)
|
||||
Net increase in cash
|
5,434
|
6,426
|
||||||
Cash and cash equivalents at beginning of year
|
19,319
|
12,893
|
||||||
Cash and cash equivalents at end of year
|
$
|
24,753
|
$
|
19,319
|
||||
Supplemental cash flow information:
|
||||||||
Cash paid for interest
|
$
|
1,389
|
$
|
1,665
|
||||
Cash paid for income taxes
|
$
|
3,202
|
$
|
3,883
|
||||
Non-cash investing activities:
|
||||||||
Receivable from sale of other invested assets
|
$ | — | $ | 12,678 |
Note 1. |
Summary of Significant Accounting Policies
|
Note 2. |
Investments
|
2021
|
||||||||||||||||
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Amortized
Cost
|
|||||||||||||
Fixed maturities:
|
||||||||||||||||
Bonds:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
50,298
|
$
|
763
|
$
|
416
|
$
|
49,951
|
||||||||
Obligations of states and political subdivisions
|
11,644
|
749
|
—
|
10,895
|
||||||||||||
Corporate securities:
|
||||||||||||||||
Utilities and telecom
|
29,717
|
2,961
|
44
|
26,800
|
||||||||||||
Financial services
|
70,921
|
6,759
|
48
|
64,210
|
||||||||||||
Other business – diversified
|
40,216
|
4,631
|
106
|
35,691
|
||||||||||||
Other consumer – diversified
|
57,940
|
7,185
|
103
|
50,858
|
||||||||||||
Total corporate securities
|
198,794
|
21,536
|
301
|
177,559
|
||||||||||||
Redeemable preferred stocks:
|
||||||||||||||||
Other consumer – diversified
|
250
|
58
|
—
|
192
|
||||||||||||
Total redeemable preferred stocks
|
250
|
58
|
—
|
192
|
||||||||||||
Total fixed maturities
|
$
|
260,986
|
$
|
23,106
|
$
|
717
|
$
|
238,597
|
2020
|
||||||||||||||||
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Amortized
Cost
|
|||||||||||||
Fixed maturities:
|
||||||||||||||||
Bonds:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
30,762
|
$
|
1,381
|
$
|
26
|
$
|
29,407
|
||||||||
Obligations of states and political subdivisions
|
11,802
|
898
|
—
|
10,904
|
||||||||||||
Corporate securities:
|
||||||||||||||||
Utilities and telecom
|
30,359
|
4,423
|
—
|
25,936
|
||||||||||||
Financial services
|
78,258
|
9,811
|
6
|
68,453
|
||||||||||||
Other business – diversified
|
41,145
|
5,689
|
15
|
35,471
|
||||||||||||
Other consumer – diversified
|
61,530
|
9,479
|
47
|
52,098
|
||||||||||||
Total corporate securities
|
211,292
|
29,402
|
68
|
181,958
|
||||||||||||
Redeemable preferred stocks:
|
||||||||||||||||
Other consumer – diversified
|
250
|
58
|
—
|
192
|
||||||||||||
Total redeemable preferred stocks
|
250
|
58
|
—
|
192
|
||||||||||||
Total fixed maturities
|
$
|
254,106
|
$
|
31,739
|
$
|
94
|
$
|
222,461
|
2021
|
||||||||||||||||
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
Equity securities:
|
||||||||||||||||
Common and non-redeemable preferred stocks:
|
||||||||||||||||
Financial services
|
799
|
525
|
—
|
274
|
||||||||||||
Other business – diversified
|
18,325
|
13,692
|
—
|
4,633
|
||||||||||||
Total equity securities
|
$
|
19,124
|
$
|
14,217
|
$
|
—
|
$
|
4,907
|
2020
|
||||||||||||||||
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
Equity securities:
|
||||||||||||||||
Common and non-redeemable preferred stocks:
|
||||||||||||||||
Financial services
|
2,111
|
351
|
—
|
1,760
|
||||||||||||
Other business – diversified
|
16,605
|
11,972
|
—
|
4,633
|
||||||||||||
Total equity securities
|
$
|
18,716
|
$
|
12,323
|
$
|
—
|
$
|
6,393
|
2021
|
2020
|
|||||||||||||||
Carrying
Value
|
Amortized
Cost
|
Carrying
Value
|
Amortized
Cost
|
|||||||||||||
Due in one year or less
|
$
|
1,734
|
$
|
1,730
|
$
|
2,041
|
$
|
2,015
|
||||||||
Due after one year through five years
|
24,926
|
23,593
|
18,373
|
17,039
|
||||||||||||
Due after five years through ten years
|
73,725
|
68,338
|
89,892
|
79,993
|
||||||||||||
Due after ten years
|
122,045
|
106,181
|
124,609
|
104,527
|
||||||||||||
Asset backed securities
|
38,556
|
38,755
|
19,191
|
18,887
|
||||||||||||
Totals
|
$
|
260,986
|
$
|
238,597
|
$
|
254,106
|
$
|
222,461
|
2021
|
||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
30,141
|
$
|
416
|
$
|
—
|
$
|
—
|
$
|
30,141
|
$
|
416
|
||||||||||||
Corporate securities
|
3,326
|
49
|
4,761
|
252
|
8,087
|
301
|
||||||||||||||||||
Total temporarily impaired securities
|
$
|
33,467
|
$
|
465
|
$
|
4,761
|
$
|
252
|
$
|
38,228
|
$
|
717
|
2020
|
||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
7,045
|
$
|
26
|
$
|
—
|
$
|
—
|
$
|
7,045
|
$
|
26
|
||||||||||||
Corporate securities
|
4,602
|
68
|
—
|
—
|
4,602
|
68
|
||||||||||||||||||
Total temporarily impaired securities
|
$
|
11,647
|
$
|
94
|
$
|
—
|
$
|
—
|
$
|
11,647
|
$
|
94
|
2021
|
2020
|
|||||||
Fixed maturities
|
$
|
8,640
|
$
|
8,646
|
||||
Equity securities
|
300
|
141
|
||||||
Other
|
(111
|
)
|
(788
|
)
|
||||
8,829
|
7,999
|
|||||||
Investment expenses
|
301
|
255
|
||||||
Net investment income
|
$
|
8,528
|
$
|
7,744
|
2021 | ||||||||||||||||
Fixed
Maturities
|
Equity
Securities
|
Other
Invested Assets
|
Total | |||||||||||||
Gains
|
$
|
570
|
$
|
—
|
$
|
4,333
|
$
|
4,903
|
||||||||
Losses
|
—
|
—
|
—
|
—
|
||||||||||||
Realized investment gains, net
|
$
|
570
|
$
|
—
|
$
|
4,333
|
$
|
4,903
|
2020 | ||||||||||||||||
Fixed
Maturities
|
Equity
Securities
|
Other
Invested Assets
|
Total | |||||||||||||
Gains
|
$
|
835
|
$
|
88
|
$
|
6,948
|
$
|
7,871
|
||||||||
Losses
|
(450
|
)
|
(1
|
)
|
—
|
(451
|
)
|
|||||||||
Realized investment gains, net
|
$
|
385
|
$
|
87
|
$
|
6,948
|
$
|
7,420
|
2021
|
2020
|
|||||||
Sales proceeds
|
$
|
9,244
|
$
|
18,504
|
||||
Gross gains
|
454
|
835
|
||||||
Gross losses
|
—
|
(450
|
)
|
2021
|
2020
|
|||||||
Sales proceeds
|
$
|
61
|
$
|
5
|
||||
Gross gains
|
—
|
—
|
||||||
Gross losses
|
—
|
(1
|
)
|
2021
|
2020
|
|||||||
Sales proceeds
|
$
|
19,761
|
$
|
—
|
||||
Gross gains
|
4,333
|
6,948
|
||||||
Gross losses
|
—
|
—
|
2021
|
2020
|
|||||||
Net realized and unrealized gains (losses) recognized during the period on equity securities
|
$
|
1,894
|
$
|
(3,344
|
)
|
|||
Less: Net realized gains recognized during the period on equity securities sold during the period
|
—
|
87
|
||||||
Unrealized gains (losses) on equity securities, net
|
$
|
1,894
|
$
|
(3,431
|
)
|
Note 3. |
Disclosures About Fair Value of Financial Instruments
|
Level 1 |
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria
include cash equivalents and exchange traded common stocks.
|
Level 2 |
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of its
fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In
determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers.
Prices for the majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable
(e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.
|
Level 3 |
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily
observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for
the asset or liability. The Company’s financial instruments valued using Level 3 criteria consist of one fixed maturity security and one equity security. As of December 31, 2021 and December 31, 2020, the value of the fixed maturity
valued using Level 3 criteria was $250 and $0, respectively. As of December 31, 2021 and December 31, 2020, the value of the equity security valued using Level 3 criteria was $157 and $143, respectively. The equity security is
not traded and valued at cost. The use of different criteria or assumptions regarding data may have yielded materially different valuations.
|
Assets:
|
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
Fixed maturities
|
$
|
250
|
$
|
260,486
|
$
|
250
|
$
|
260,986
|
||||||||
Equity securities
|
18,967
|
—
|
157
|
19,124
|
||||||||||||
Cash equivalents
|
12,713
|
—
|
—
|
12,713
|
||||||||||||
Total
|
$
|
31,930
|
$
|
260,486
|
$
|
407
|
$
|
292,823
|
Assets:
|
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
Fixed maturities
|
$
|
—
|
$
|
254,106
|
$
|
—
|
$
|
254,106
|
||||||||
Equity securities
|
18,573
|
—
|
143
|
18,716
|
||||||||||||